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ABSTRACT 
Raktapradar is a most common gynecological problem found in PTSR. It is not a disease but a 
symptom found in many gynaecological disorders. Most of the gynaecological disorder comes under 
the heading of Yonivyapad in Ayurvedic classics. It has an associated complication like Pandu and 
sterility. Hence Vasadi churna with Tandulodak is chosen to study its effect in Raktapradar. 
Method: A clinical trial was conducted in indoor and outdoor patient diagnosed with Raktapradar. 
The 30 patient was given with an Ayurvedic drug and monitored according to protocol including 
clinical and pathological parameter. The criteria for selection of patient are inclusive and exclusive. 
Patient from inclusive criteria have excessive bleeding p/v was selected. Clinical symptoms were 
assessed with four grades as follow no change, marked, moderate, and severe. Criteria for 
assessment were marked, moderate and mild. Results: Results were noted and it was observed that 
selected drug is safe and effective. 
KEYWORDS: Raktapradar, Vasadi yoga, Adhatoda vasica, Bleeding per vagina. 
INTRODUCTION 
 Ayurveda is a science of life which explain us 
how to live and enjoy a healthy life. From Vedic age 
people followed Ayurveda for curing their disease. 
Human life is constantly influenced by the rhythmic 
phenomenon operating in this universe. Health is the 
actual way of attaining longevity in all species 
including human being. The female menstrual cycle 
involves dramatic monthly hormonal changes 
affecting a women’s emotional and physical state. 
Acharya Charak mentioned that Garbha (new 
progeny) can be resides only in Suddha yoni. That is 
why Ayurveda has explained woman’s health in 
details and emphasized on all the preventive as well 
as curative measures to preserve it in the healthiest 
state. Ayurveda has described many fundamental 
concepts like Dosha, Dhatu with their Updhatu and 
Mala. Artava is the Upadhatu of Rasa dhatu. Ati means 
excessive and Artava means menstrual blood. In 
Ayurveda the condition of excessive bleeding during 
menstruation is known as Raktapradar. This 
condition arises when Pitta and Vata get vitiated. 
Abnormal uterine bleeding is defined as any 
variation from the normal menstrual cycle, and 
includes changes in regularity and frequency of 
menses, in duration of flow, or in amount of blood 
loss[1]. It is a problem mostly prevalent in 
reproductive age group worldwide and affects quality 
of life. It has got different detrimental effects on 
individual and community. For instances, school and 
work absenteeism, interference with daily activities, 
limitation to socialization and higher intake of 
NSAIDs and haemostatics are positively associated 
with higher prevalence and intensity of menorrhagia. 
Menorrhagia is essentially a symptom and not 
itself a disease. It affects 20-30% woman at sometime 
or other with significant adverse effect on the quality 
of life in terms of anaemia, cost of sanitary pads and 
interference in day-to-day activities. .Several causes 
may prevail in a few cases, and attribute to excess 
bleeding. In excessive bleeding with regular cycle, H-
P-O axis is intact, but endometrial changes get 
altered. It is observed that in these cases, PGI2 
(prostacyclin), which is a vasodilator is increased as 
compared to PGF2a (carboprost) in endometrial 
tissue. 
The treatment protocol for Raktapradar is 
based on correction of Pitta dosa Anubandhi Vata 
dosha along with Rakta dhatu. Vata dosha is the root 
cause of all the Yoni dushti[2]. The drug selected for 
the present study is Vasadi yoga which corrects Pitta-
vaigunya and thus pacifies Apana vayu in specific as 
Apana vayu is Anubandha dosha here and is 
responsible for Raja Nishkramana[3]. 
Almost all Ayurvedic classics emphasized the 
concept of Raktapradar which highlights the 
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importance given to the subject. This study aimed at 
systematic compilation, analysis and interpretation 
of the concepts of Raktapradar with the 
contemporary science, understanding the concepts of 
abnormal uterine bleeding from an Ayurvedic 
perspective and to assess the efficacy of the trial drug 
i.e., Vasadi yoga in the treatment of it. 
Various treatments like hormonal therapy, 
anti prostaglandin and anti fibrinolytic agents are 
available in modern health science. Many side effects 
have been observed because of medication and 
hysterectomy leading to hormonal imbalance and 
psychological upset in young fertile women. So 
keeping in mind I took Ayurvedic drug which are non-
hormonal and safe that could provide effective 
alternative for Raktapradar. I have selected Vasadi 
yoga with Tandulodak which has been mentioned in 
Yogaratnakar due to its contents, cost effectiveness 
and disease healing property. 
The combined formulation selected for 
treatment is based on following properties. Vasa have 
a property of Rakta pittaghna and its leaves act as 
vasoconstrictor. Yasthimadhu has property of 
Dahashamak and Vatapittaghna and Misri has Vata, 
Pitta and Rakta Doshahara properties along with 
Tandulodak as Anupan which increases the potency 
of the drug action so here I attempted to evaluate the 
efficacy of Vasadi Yoga with Tandulodak in the 
management of Raktapradar. 
MATERIAL AND METHODS 
METHOD 
30 patient from experimental group as per 
previously stated criteria were selected and provided 
Vasadi yoga (5gm) twice daily orally with Tandulodak 
as Anupan.  
Work Profile 
Criteria for selection of patient were- 
1. Inclusive Criteria 
 Patient between age group of 12-50 year of age 
 Patients with Lakshana of Raktapradar like 
prolong, excessive menstrual bleeding and 
intermenstrual bleeding.(According to Ayurvedic 
reference [4,5,6] (C.S.Chi30/208, Su.S.Sa 2/18,19, 
A.S.Sa 1/11) 
2. Exclusive Criteria: Patient having other 
associated complications such as Fibroid, Polyp, 
Malignancy, Hypertension, Tuberculosis, Diabetes 
mellitus, Blood dyscracias was excluded from 
study point of view. 
Investigation 
Following investigations were done 
a) Blood routine examination,  
 
 
b) Bleeding and Clotting Time, Blood sugar 
c) Platelet count 
d) VDRL, HIV, HBsAg, HCV  
e) USG lower abdomen to know about any pelvic 
pathology and endometrium 
f) Urine for HCG 
g) FSH, LH 
h) Others as required for the patient concerned. 
Trial Methodology 
The study was performed in a randomized open trial. 
Preparation of the Trial Drug 
 Vasa plants are collected fresh from local area and 
cleaned in running water then dried properly in drier 
machine. Dried Yasthimadhu root and Misri was 
collected. After proper drying these entire 
ingredients were taken in equal quantity and was 
grinded and made into fine powder. Packaging done 
for prepared formulation where single packet of drug 
contains 150gm. The preparation is done in 
Rasashala of Govt. Ayurvedic College and Hospital. 
The Churna was tested in State Drug Testing 
Laboratory (AYUSH), Guwahati. Authenticity of 
material was confirmed by expert of respective field, 
there originality, purity was identified and selected 
as per standard mentioned in Ayurvedic 
Pharmacopoeia of India (API). 
Dose and Duration of Treatment 
The prepared formulation is given in the dose 
10gm in two divided doses after meal with 40ml 
Tandulodak (with each dose) for 3 consecutive 
menstrual cycle. 
Assessment Parameter 
Control trial selection of method patient from 
indoor and outdoor department as per previous 
stated criteria were selected. As per proforma of case 
sheet, detail history, clinical findings were recorded. 
Following sign and symptoms for assessment were as 
follow  
 Raja Srava pramana: It will be assessed by 
number of used sanitary pads per day (Raja 
Pradirana). Women were advised to use standard 
sized sanitary pads 15x7.5x2.5cm made of cotton 
and scoring is done purely on the basis of the 
patient’s statement. 
 Raja Srava Kaal: The duration of bleeding phase 
will be assessed by comparing with previous 
menstrual history the patient (Raja srava avadhi). 
 Anaritukaal: Duration of intermenstrual period. 
 Vedana: association of pain abdomen during 
menstruation 
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Gradation of the Sign and Symptoms 
A) Srava kaala (Duration of Bleeding) 
Duration in Days Remarks Grading 
2-3 Average 0 
4-5 Mild prolonged 1 
6-7 Moderately prolonged 2 
8-10 Prolonged 3 
>10 Very prolonged 4 
B) Sravamaana (Quantity of bleeding) 
No. of Pads used in 24 hours Remarks Grading 
Maximum soakage of 1-2 pads in 24hours Average 0 
Maximum soakage of 3-4 pads in 24hours Mild excessive 1 
Maximum soakage of 5-6 pads in 24hours Moderately excessive 2 
Maximum soakage of 6-7 pads in 24hours Excessive 3 
Maximum soakage of more than 7 pads in 24hours Highly excessive 4 
C) Anaritukaal (Intermenstrual period) 
Duration of intermenstrual period Remark Grading 
26-30 days Average 0 
21-25 days Short 1 
15-20 days Very short 2 
<15 days Extremely short 3 
D) Vedana (pain during menstruation) 
Extent of pain Remark Grading 
No pain during menstruation Average 0 
Complaints of pain but do not require medical 
assistance, do not affect daily activity 
Mild pain 1 
Complaints of pain generally take random medicine, 
do not affect daily activity severely 
Moderate pain 2 
Complaints of pain, bound to take medicine and it is 
effective, affects daily activity 
Severe pain 3 
Complaints of pain, bound to take medicine and it is 
not that much effective, affects daily activity severely. 
Very severe pain 4 
RESULT  
In this present study, total 30 numbers of 
patients were given treatment along with follow up 
of three consecutive cycles. 
Pre-Observation 
Duration of Menstrual Period 
It is evident from the study that maximum i.e., 
50% patients were having duration of menstrual 
period of 8-10 days, while 46.67% had 6-7 days and 
3.33% patients had menstrual period of duration 4-5 
days. No patient was found with menstrual period 
more than 10 days. 
 
Amount of Blood Loss per Cycle 
It is evident from the study that maximum i.e. 
43.33% patients were found with maximum soakage 
of 6-7 pads in 24 hours, while 40% patients were 
with maximum soakage of more than 7 pads in 24 
hours, 10% patients were found with maximum 
soakage of 5-6 pads in 24 hours and 6.67% were 
found with maximum soakage of 3-4pads in 24 hours. 
Duration of intermenstrual period 
It is evident that maximum i.e., 66.67% 
patients were having duration of intermenstrual 
period of 26-30 days, while 26.67% had 21-25 days 
and remaining 6.66% patients had intermenstrual 
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period of duration 15-20 days. No patient was found 
with duration of intermenstrual period less than 15 
days. 
Association of pain with chief complaints 
It is clear from the study that out of 30 
patients, 8 patients i.e. 26.67% had no pain abdomen 
during menstruation. 14 numbers of patients i.e., 
46.67% had complaints of pain during menstruation 
but do not require any medical assistance and it do 
not affect daily activity at all. 1 patient had 
complaints of pain generally take random medicine; 
do not affect daily activity severely. 4 numbers of 
patients i.e., 13.3% had complaints of pain which 
affect daily activities and bound to take medicine and 
it is effective. 3 numbers of patients i.e., 10% had 
complaints of pain which affect daily activities badly 
and bound to take medicine and it is not that much 
effective. 
Demographic Review 
Table 2: Age Wise Distribution of 30 Patients 
Serial no. Age Number of patients Percentage 
1 12-20 year 1 3.34% 
2 21-30 year 7 23.34% 
3 31-40 year 18 60% 
4 41-50 year 4 13.34% 
Table 3: Marital Status Wise Distribution of 30 Patients 
Serial no. Marital Status Number of Patients Percentage 
1 Married 24 80% 
2 Unmarried 6 20% 
Table 4: Occupation Wise Distribution of 30 Patients 
Serial no. Occupation Number of patients Percentage 
1 Student 3 10% 
2 House -wife 20 66.67% 
3 Service 7 23.34% 
Statistical Review 
Table 5: Effect of Trial Drug on Symptoms of Raktapradar on 1st Follow-up 
S. No. Symptoms 𝑿 BT 𝑿 AT 𝑿 BT-AT SDBT-AT SE t-value P Remarks 
1 Srava Kala (N=30) 2.5 1.8 0.63 0.47 0.08 7.87 <.001 Highly Significant  
2 Sravapraman (N=30) 3.1 2.5 0.6 0.55 0.1 6 <0.001 Highly Significant  
3 Anaritukaal (N=10) 1.2 0.4 0.8 0.41 0.13 6.15 <0.001 Highly significant  
4 Vedana (N= 22) 1.8 1.2 0.54 0.79 0.17 3.17 <0.01 Significant  
Table 6: Effect of Trial Drug on Symptoms of Raktapradar on 2nd Follow-up 
S. No. Symptoms 𝑿 BT 𝑿 AT 𝑿 BT-AT SD BT-AT SE t-value P Remarks 
1 Srava Kala (N=30) 2.5 1.2 1.26 0.50 0.09 14 <.001 Highly Significant  
2 Sravapraman (N=30 3.1 1.8 1.3 0.64 0.1 13 <.001 Highly Significant  
3 Anaritukaal (N=10) 1.2 0.3 0.9 0.56 0.18 5 <.001 highly significant  
4 Vedana (N= 22) 1.8 1 0.72 0.81 0.17 4.23 <.001 Highly Significant  
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Table 7: Effect of Trial Drug on Symptoms of Raktapradar on 3rd Followup 
S.No. Symptoms 𝑿 BT 𝑿 AT 𝑿 BT-AT SD BT-AT SE t-value P Remarks 
1 Srava Kala N=30 2.5 0.9 1.6 0.55 0.10 16 <.001 Highly Significant  
2 SravapramanN=30 3.1 1.3 1.86 0.67 0.12 15.5 <.001 Highly Significant  
3 Anaritukaal N=10 1.2 0.1 1.1 0.56 0.18 6.1 <.001 Highly significant  
4 Vedana N= 22 1.8 0.6 1.2 0.96 0.2 6 <.001 Highly Significant  
N= number of patients 
Table 8: Final Assessment 
After completion of the trial, the statistical 
evaluation showed following results in individual 
sign and symptoms: 
1. Srava Kala (Duration of Bleeding): Clinically out 
of 30 total patients, all the 30 patients had the 
symptoms. After the treatment 3 patients i.e., 10% 
had complete cure, 27 patients i.e., 90% patients 
had moderate improvement. 
2. Srava Praman (Amount of Bleeding): Clinically 
out of 30 total patients, all the 30 patients had the 
symptom. After the treatment 3 patients i.e., 10% 
had complete cure, 15 patients i.e., 50% patients 
had moderate improvement and 12 patients i.e., 
40% shows mild improvement. No any patients 
remain unchanged.  
3. Anaritukaal (Duration of Intermenstrual 
Period): Clinically out of 30 patients, 10 patients 
are found with shortened intermenstrual period. 
After treatment 9 patients i.e. 90% had complete 
cure and rest 1 patient had no improvement i.e. 
10%. 
4. Vedana (pain abdomen during menstruation): 
Clinically 22 patients out of 30 had the symptom. 
After treatment 10 patients i.e. 45.45% got 
complete cure, 6 patients i.e. 27.27% % had 
moderate improvement, 1 patient i.e., 4.54% had 
mild improvement and 5 patients i.e., 22.7% had 
no improvement. 
DISCUSSION 
Probable Mode of Action of Trial Drug 
In the present study the trial drug is 
formulated namely Vasadi Yoga. The trial drug Vasadi 
Yoga has reference in “Yogaratnakar strirogadhikar 
pradar chikitsa".[7] 
The ingredients of Vasadi Yoga are- Vasa, 
Yasthimadhu, Misri. All the drugs were taken in equal 
parts and made into Churna form of 150gm each. 
Except indications, there is no reference of 
Rasa, Guna etc of this formulation. Hence the Rasa 
Guna etc, whatever description of the individual 
drugs found is mentioned to have an overall idea in 
respective places. To understand this scientifically 
we should consider the related basic fundamentals, 
which are described in the classics as 
i) The conjugation of Rasas (Rasa Sannipata) to their 
mutual subordination and variation in processing 
on the basis of Prakriti Sama Samavaya and 
Vikriti-Visham-Samavaya (Chakrapani) theories 
are to be analyzed decide the total effect 
(Samudaya Prabhava) of the drug on the Doshas 
(or disease). It is because the active ingredients in 
a compound formulation show either antagonism 
(Parasparena Cha Upahatanama) or synergism 
(Abhivardhana) effects [8]. (Ch. Vi. 1/7). 
ii) The drugs are active due to their own inherent 
constituents (Dravya Prabhāva), properties (Guna 
Prabhava) and both combined (Dravyaguna 
Prabhava) together in particular time, on reaching 
particular site, with a particular mechanism and 
objective.[9] (Ch Su. 26/13) 
iii) The different properties of a drug are inferred by 
observing their effects on the body[10]. (Su. Su. 
46/521) 
Symptoms Before 
treatment 
After treatment 
Cured Moderate 
Improvement 
Mild 
Improvement 
Unchanged 
No. of 
Patients 
% No. of 
Patients 
% No. of 
Patients 
% No. of 
Patient 
% No. of 
Patient 
% 
Srava Kala 30 100 03 10 27 90 00 00 00 00 
Sravapraman 30 100 03 10 15 50 12 40 00 00 
Anaritukaal 10 33.33 09 90 00 00 00 00 01 10 
Vedana 22 73.33 10 45.45 6 27.27 01 4.54 05 22.7 
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Therefore keeping the above view in mind, 
we can establish the possible properties, action and 
mode of action of the trial drug by observing the 
clinical and pharmacological effect. 
Hence the pharmacological property of 
Vasadi Yoga can be explained as 
 Rasa- Kashaya, Madhur 
 Guna- ruksha, Laghu 
 Virya- Sheeta 
 Vipak- Katu 
Acharya Charak explained Raktapradar as 
disease of vitiated Rakta and Pittavrit vata and Apana 
vayu[11]. (C.Chi 30/202) 
Most of the ingredients of treatment of 
Raktapradar contain Kashaya Madhur Rasa, Laghu 
Ruksha Guna, Sheeta Virya properties due to Kashaya 
Madhur Rasa, it has Grahi action so it is indicated in 
all bleeding condition.  
In the pathogenesis of Raktapradar Chala 
Guna of Vata Dosha and Drava Guna of Pitta Dosha 
increase the amount of blood. Hence these drugs 
might affect the Sara and Drava Guna of Pitta Dosha 
with the help of Ruksha, Laghu Guna and Kashaya 
Rasa so this could be reason in reducing the amount 
of bleeding. 
Cholesterol the precursor of all steroid 
hormones, especially in female is responsible for 
more production of oestrogen. Kaphashamak and 
Lekhaniya karma are probably carried out by Laghu 
and Ruksha Guna of Vasa therefore it decreases the 
production of oestrogen leading to reduced 
hyperplasia of endometrium. 
Hence in the pathogenesis of Raktapradar, 
Chala Guna of Vata, Sara and Drava Guna of Pitta 
increase the amount of blood, hence these drug might 
affect Sara and Drava Guna of Pitta Dosha with the 
help of Ruksha Laghu Guna and Kashaya Rasa as a 
result it decrease the amount of bleeding. 
Discussion on the Observation of Demographic 
Profile 
From age point of view, it was found that out 
of 30 patients, maximum number of patients i.e. 60% 
belonged to the age group 31-40 years, followed by 
23.34% of age group 21-30 years and 3.34% belong 
to age group of 12-20 years each. It may indicate 
towards the less awareness about self health and 
stressful life of housewives with age above 31years.  
Data shows married woman suffers from 
menorrhagia more i.e., 80% compared to unmarried 
woman i.e., 20%. That may indicate towards stressed 
psychological status and less health awareness 
among housewives as this study also shows 
maximum number of patients i.e., 66.67% were 
housewives followed by 23.34% were service woman 
and only 10% patients were students.  
DISCUSSION ON RESULT 
On Cardinal Symptom of the disease: After three 
months of the trial, the findings are as shown below 
1. On Sravakala (duration of bleeding) after 
treatment t29=16, P<.001, hence the effect of trial 
drug is found highly significant.  
2. On Sravapraman (quantity of bleeding) after 
treatment t29=15.5, P<.001, hence the effect of 
trial drug is found highly significant.  
3. On Anaritukaal (Intermenstrual duration) after 
treatment t9=6.1, P<.001, hence the effect of trial 
drug is found highly significant. 
4. On Vedana (pain abdomen during menstruation) 
after treatment t21= 6, P<.001 hence the effect of 
trial drug is found highly significant.  
Table 6 and table 7 showed that the trial drug 
showed its effect from the first follow-up. 
CONCLUSION 
1. The clinical condition of Raktapradar is more or 
less similar to abnormal uterine bleeding or 
Dysfunctional uterine bleeding. 
2. Treatment protocol of Raktapradar should be 
done in the line of Raktapitta Chikitsa. 
3. The formulation selected for the present study is 
Vasadi yoga where Vasa is considered as best 
Raktapittaghna drug. Besides Tandulodak can be 
prescribed as best Anupan in Raktapradar. Other 
ingredients such as Yasthimadhu and Misri act as 
Pittashamak. 
4. The trial drug showed encouraging result in 
symptoms associated with Raktapradar without 
having any toxicity or adverse effect in the body. 
5. Trial drug has shown to be effective in excessive 
and prolong bleeding by reducing both amount 
and duration of blood loss, normalizing 
intermenstrual period and also relieved pain. 
6. Drug is very cheap, widely available and can be 
easily prepared at home. 
7. Further study on larger sample with assessment 
of biochemical and experimental parameter are 
needed for more precise conclusion of the drug in 
order to establish its efficacy in Raktapradar. 
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